Company Search:
Advanced Search
Sponsored Links
Luye Pharma Group Limited Company Snapshot
Luye Pharma Group Limited operates in the Medicinals and botanicals sector. In addition to historical fundamental analyses, the complete report available to purchase compares Luye Pharma Group Limited with three other pharmaceutical manufacturers in Asia: ChangChun High New Technology Industries of China (2016 sales of 2.87 billion Chinese Renmimbi [US$446.46 million] of which 81% was Medication), Kimia Farma (Persero) Tbk PT of Indonesia (5.81 trillion Indonesian Rupiahs [US$435.86 million] of which 52% was Retail), and Hunan ER-KANG Pharmaceutical Co Ltd which is based in China (2.96 billion Chinese Renmimbi [US$459.97 million] of which 92% was Manufacture of Medicines).

Sales Analysis. Luye Pharma Group Limited reported sales of 605.73 million Singapore Dollars (US$458.54 million) for the year ending December of 2016. This represents an increase of 7.8% versus 2015, when the company's sales were 561.71 million Singapore Dollars. Despite this increase, sales are still below the level achieved in 2014, when Luye Pharma Group Limited reported sales of 649.30 million Singapore Dollars. Sales of Other saw an increase that was more than double the company's growth rate: sales were up 71.4% in 2016, from 17.14 million Singapore Dollars to 29.37 million Singapore Dollars. Luye Pharma Group Limited also saw significant increases in sales in Alimentary Tract and Metabolism Drugs (up 12.2% to 115.11 million Singapore Dollars) . Not all segments of Luye Pharma Group Limited experienced an increase in sales in 2016: sales of Cardio-Vascular System Drugs fell 0.6% to 135.33 million Singapore Dollars.
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Luye Pharma Group Limited
  Stock Performance Chart for Luye Pharma Group Limited
  Stock Data: Recent Stock Performance:
  Current Price (1/12/2018): 1.22
(Figures in Singapore Dollars)
1 Week 13.4%   13 Weeks 30.2%  
4 Weeks 51.5%   52 Weeks 39.8%  
Luye Pharma Group Limited Key Data:
  Ticker: 2186 Country: China
  Exchanges: HKG Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Medicinals & Botanicals
  2016 Sales 605,734,034
(Year Ending Jan 2017).
Employees: 3,492
  Currency: Singapore Dollars Market Cap: 4,059,149,294
  Fiscal Yr Ends: December Shares Outstanding: 3,321,073,843
  Share Type: Ordinary Closely Held Shares: 1,713,675,625
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.